Seized drugs
Application of Ambient Sampling Portable Mass Spectrometers Toward On-Site Screening of Clandestine Drug Operations
Separation mechanism of chiral impurities ephedrine and pseudoephedrine found in amphetamine-type substances using achiral modifiers in the gas phase
Regioisomeric bromodimethoxy benzyl piperazines related to the designer substance 4-bromo-2,5-dimethoxybenzylpiperazine: GC–MS and FTIR analysis
Differentiation of trifluoromethylbenzylpiperazines (TFMBZPs) and trifluoromethylbenzoyl-piperazines (TFMBOPs) by GC-MS
Efficient Casework Policy To Address Emerging Challenges in Seized Drugs
Evaluation of Commercial Enzyme Linked Immunosorbent Assays to Identify Psychedelic Phenethylamines
Analysis of volatile components of drugs and explosives by solid phase microextraction-ion mobility spectrometry
The Opioid Epidemic: Moving Toward an Integrated, Holistic Analytical Response
Surface-Enhanced Raman Spectroscopy for Trace Identification of Controlled Substances: Morphine, Codeine, and Hydrocodone
Elimination of 7-Aminoflunitrazepam and Flunitrazepam in Urine After a Single Dose of Rohypnol
Qualitative Analysis of Seized Synthetic Cannabinoids and Synthetic Cathinones by Gas Chromatography Triple Quadrupole Tandem Mass Spectrometry
Simultaneous Separation of Different Types of Amphetamine and Piperazine Designer Drugs by Capillary Electrophoresis with a Chiral Selector
Comparative Analysis of Gamma-Hydroxybutyrate and Gamma-Hydroxyvalerate Using GC/MS and HPLC
Qualitative Analysis and Detection of the Pyrolytic Products of JWH-018 and 11 Additional Synthetic Cannabinoids in the Presence of Common Herbal Smoking Substrates
Assessment of Ultra High Performance Supercritical Fluid Chromatography as a Separation Technique for the Analysis of Seized Drugs: Applicability to Synthetic Cannabinoids
Microfluidic Device for Presumptive Testing of Controlled Substances
Recent Advances in Comprehensive Chromatographic Analysis of Emerging Drugs
Quantification of Cocaine in Ternary Mixtures Using Partial Least Squares Regression Applied to Raman and Fourier Transform Infrared Spectroscopy
Office of Justice Programs (OJP) / Centers for Disease Control and Prevention (CDC) Federal Medicolegal Death Investigation Interagency Working Group (MDI-IWG) Resource Page
The Department of Justice’s (DOJ) Office of Justice Programs (OJP) and the U.S. Health and Human Services’ (HHS) Center for Disease Control and Prevention (CDC) established this Federal Medicolegal Death Investigation (MDI) Interagency Working Group (MDI-IWG) to coordinate Federal initiatives to strengthen MDI systems and support death investigation services practiced by medical examiner and coroner offices (MECs) across the United States. The MDI-IWG commenced in...